How many insider trades does FilingIQ track for DFTX?

FilingIQ tracks 9 Form 4 insider transactions for DFTX (Definium Therapeutics, Inc.), covering filings from Jan 29, 2026 onwards. 3 of those were filed in the last 90 days.

Are DFTX insiders net buyers or net sellers?

Across the full Form 4 history for DFTX, 0 transactions (0%) were open-market purchases and 3 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does DFTX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is DFTX in?

Definium Therapeutics, Inc. (DFTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.64B.

DFTX insider trading

Healthcare

Definium Therapeutics, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

Last 90 days

Buys / sells

0% / 33%

Market cap

$1.64B

About Definium Therapeutics, Inc.

Definium Therapeutics, Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM120, which is in phase 3 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and DT402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase 2a clinical trials for the treatment of core symptoms of autism spectrum disorder. The company was formerly known as Mind Medicine (MindMed) Inc. and changed its name to Definium Therapeutics, Inc. in January 2026. Definium Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

Company website: definiumtx.com

DFTX insider activity at a glance

FilingIQ has scored 9 insider transactions for DFTX since Jan 29, 2026. The most recent filing in our index is dated Mar 25, 2026.

Across the full history, 0 open-market purchases and 3 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

View live DFTX trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for DFTX?: FilingIQ tracks 9 Form 4 insider transactions for DFTX (Definium Therapeutics, Inc.), covering filings from Jan 29, 2026 onwards. 3 of those were filed in the last 90 days.
Are DFTX insiders net buyers or net sellers?: Across the full Form 4 history for DFTX, 0 transactions (0%) were open-market purchases and 3 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does DFTX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is DFTX in?: Definium Therapeutics, Inc. (DFTX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.64B.

Methodology & sources

Every DFTX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.